Methiodone
Opioid, Habit-forming, Depressant
Methiodone (IC-26, WIN 1161-3) is a synthetic opioid analgesic and methadone analogue developed by Sterling Drug Inc. In human studies, low oral doses frequently produced no clear subjective effects, while higher doses induced morphine-like effects with significant inter-individual variability. Twenty-four-hour substitution studies demonstrated that IC-26 effectively suppressed morphine withdrawal, and its addiction liability was concluded to be comparable to morphine.
Oral (exact value unknown).
Unknown.
Please be aware that with research chemicals purchased from grey-market vendors, one can never be 100% certain of the actual amount or purity of the active compound. Tread lightly.
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Strong
Heavy
Oral
5-10mg
10-20mg
20-35mg
35mg+
Onset
Duration
After Effects
Oral
45m to 2
6 to 24
6 to 48
Analgesia, Euphoria, Sedation, Respiratory depression, Mood lift, Itchiness, Dry mouth, Pupil constriction, Physical relaxation
Wolbach AB, Fraser HF. Addiction Liability of I-C-26. Bulletin on Narcotics, 1963.Janssen PA. Synthetic Analgesics Vol. 1. Pergamon Press, 1960.Lednicer D. Central Analgetics. Wiley, 1982.US Patent 2,618,640 – Certain Amino Hydrocarbon Sulfones and Process of Preparation (Archer, Suter, Tullar; Sterling Drug Inc.).